204 related articles for article (PubMed ID: 31446462)
1. Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.
Uchiyama S; Goto S; Origasa H; Uemura N; Sugano K; Hiraishi H; Shimada K; Okada Y; Ikeda Y;
Heart Vessels; 2020 Feb; 35(2):170-176. PubMed ID: 31446462
[TBL] [Abstract][Full Text] [Related]
2. Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF Registry.
Fukamachi D; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Nishida T; Kojima T; Hanada S; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Curr Med Res Opin; 2019 Dec; 35(12):2053-2062. PubMed ID: 31355684
[No Abstract] [Full Text] [Related]
3. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.
Glynn RJ; Ridker PM; Goldhaber SZ; Buring JE
Ann Intern Med; 2007 Oct; 147(8):525-33. PubMed ID: 17938390
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (
Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of complications of antithrombotic treatment in patients with atrial fibrillation].
Novaković Anucin S; Gnip S; Canak V; Radović P; Kovacev J; Mitić G
Med Pregl; 2013; 66(11-12):470-5. PubMed ID: 24575635
[TBL] [Abstract][Full Text] [Related]
6. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
8. Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler DO MJ; Day JD; Mallender C; Osborn JS; Weiss JP; Bunch TJ
J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1241-1246. PubMed ID: 28845890
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Occurrence of venous thromboembolism in women taking low-dose aspirin.
Ann Intern Med; 2007 Oct; 147(8):I34. PubMed ID: 17938386
[No Abstract] [Full Text] [Related]
10. Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan.
Miyamoto S; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Minematsu K; Murakawa Y; Iwashiro S; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104584. PubMed ID: 31983518
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for Primary Prevention of Cardiovascular Events.
Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL
J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447
[TBL] [Abstract][Full Text] [Related]
12. Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events.
Schaefer JK; Li Y; Gu X; Souphis NM; Haymart B; Kline-Rogers E; Almany SL; Kaatz S; Kozlowski JH; Krol GD; Sood SL; Froehlich JB; Barnes GD
JAMA Intern Med; 2019 Apr; 179(4):533-541. PubMed ID: 30830172
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
14. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C
Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.
Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M
Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346
[TBL] [Abstract][Full Text] [Related]
16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
17. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
18. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
[TBL] [Abstract][Full Text] [Related]
19. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
; Bowman L; Mafham M; Wallendszus K; Stevens W; Buck G; Barton J; Murphy K; Aung T; Haynes R; Cox J; Murawska A; Young A; Lay M; Chen F; Sammons E; Waters E; Adler A; Bodansky J; Farmer A; McPherson R; Neil A; Simpson D; Peto R; Baigent C; Collins R; Parish S; Armitage J
N Engl J Med; 2018 Oct; 379(16):1529-1539. PubMed ID: 30146931
[TBL] [Abstract][Full Text] [Related]
20. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
